The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling
Open accessAbstract
Hypoxia induces rapid and dramatic changes in cellular metabolism, in part through inhibition of target of rapamycin (TOR) kinase complex 1 (TORC1) activity. Genetic studies have shown the tuberous sclerosis tumor suppressors TSC1/2 and the REDD1 protein to be essential for hypoxia regulation of TORC1 activity in Drosophila and in mammalian cells. The molecular mechanism and physiologic significance of this effect of hypoxia remain unknown. Here, we demonstrate that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing TSC2 from its growth factor-induced association with inhibitory 14–3–3 proteins. Endogenous REDD1 is required for both dissociation of endogenous TSC2/14–3–3 and inhibition of mTORC1 in response to hypoxia. REDD1 mutants that fail to bind 14–3–3 are defective in eliciting TSC2/14–3–3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1. In vitro, loss of REDD1 signaling promotes proliferation and anchorage-independent growth under hypoxia through mTORC1 dysregulation. In vivo, REDD1 loss elicits tumorigenesis in a mouse model, and down-regulation of REDD1 is observed in a subset of human cancers. Together, these findings define a molecular mechanism of signal integration by TSC1/2 that provides insight into the ability of REDD1 to function in a hypoxia-dependent tumor suppressor pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recent study showed that endogenous Redd1 is required for both dissociation of endogenous TSC2/14–3-3 proteins and inhibition of mTOR in response to hypoxia [127].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [127]
In the citing paper
“Another example of this localization dependency includes hypoxia-dependent regulation through REDD1 (Brugarolas et al., 2004), which disrupts cytosolic 14-3-3-bound TSC2 and enables subsequent TSC2 localization to the lysosome where it can inhibit Rheb (DeYoung et al., 2008).”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as DeYoung et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,590
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
Self-citationGene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J., van de Rijn, M., Bair, E., Montgomery, K. D., Ferrari, M. K., Egevad, L., Rayford, W., Bergerheim, U. S. R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,282
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 710
Structural Analysis and Functional Implications of the Negative mTORC1 Regulator REDD1,
Vega-Rubín-de-Celis, S., Abdallah, Z., Kinch, L. N., Grishin, N. V., Brugarolas, J., & Zhang, X. (2010) · Biochemistry · doi:10.1021/bi902135e · Cited by 81
Mammalian TOR signaling to the AGC kinases
Su, B., & Jacinto, E. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.618113 · Cited by 79
Mu, N., Lei, Y., Wang, Y., Wang, Y., Duan, Q., Ma, G., Liu, X., & Su, L. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01559-3 · Cited by 75
Missiaen, R., Lesner, N. P., & Simon, M. C. (2023) · The EMBO Journal · doi:10.15252/embj.2022112067 · Cited by 78
Sorek, M., Schnytzer, Y., Ben‐Asher, H. W., Caspi, V. C., Chen, C.-S., Miller, D. J., & Levy, O. (2018) · Microbiome · doi:10.1186/s40168-018-0465-9 · Cited by 67
Yamada, Y., Takayama, K., Fujimura, T., Ashikari, D., Obinata, D., Takahashi, S., Ikeda, K., Kakutani, S., Urano, T., Fukuhara, H., et al. (2016) · Cancer Science · doi:10.1111/cas.13105 · Cited by 73
Expression of mTOR in normal and pathological conditions
Marques-Ramos, A., & Cervantes, R. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01820-z · Cited by 77
Is REDD1 a metabolic double agent? Lessons from physiology and pathology
Britto, F. A., Dumas, K., Giorgetti‐Peraldi, S., Ollendorff, V., & Favier, F. B. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00340.2020 · Cited by 72
Paligenosis: Cellular Remodeling During Tissue Repair
Brown, J. W., Cho, C. J., & Mills, J. C. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061121-035954 · Cited by 68
Thermal plasticity of the miRNA transcriptome during Senegalese sole development
Campos, C., Sundaram, A. Y. M., Valente, L. M. P., Conceição, L. E. C., Engrola, S. A. D., & Fernandes, J. M. O. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-525 · Cited by 71
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer
Jin, Y., Qu, S., Tesikova, M., Wang, L., Kristian, A., Mælandsmo, G. M., Kong, H., Zhang, T., Jerónimo, C., Teixeira, M. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304318110 · Cited by 70
AMPK regulates metabolism and survival in response to ionizing radiation
Zannella, V. E., Cojocari, D., Hilgendorf, S., Vellanki, R. N., Chung, S., Wouters, B. G., & Koritzinsky, M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.049 · Cited by 68
TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium
Zhou, Y., Rychahou, P. G., Wang, Q., Weiss, H. L., & Evers, B. M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.588 · Cited by 72
Lin, C., Robert, F., Sukarieh, R., Michnick, S. W., & Pelletier, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4072 · Cited by 69
Characterization of the Intrinsic and TSC2-GAP–Regulated GTPase Activity of Rheb by Real-Time NMR
Marshall, C. B., Ho, J., Buerger, C., Plevin, M. J., Li, G., Li, Z., Ikura, M., & Stambolic, V. (2009) · Science Signaling · doi:10.1126/scisignal.2000029 · Cited by 70
Matthew, E. M., Hart, L. S., Astrinidis, A., Navaraj, A., Dolloff, N. G., Dicker, D. T., Henske, E. P., & El-Deiry, W. S. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10800 · Cited by 67
Yu, F., Zhu, A. C., Liu, S., Gao, B., Wang, Y., Khudaverdyan, N., Yu, C., Wu, Q., Jiang, Y., Song, J., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.05.010 · Cited by 69
14-3-3 Proteins are Regulators of Autophagy
Pozuelo-Rubio, M. (2012) · Cells · doi:10.3390/cells1040754 · Cited by 67
Targeting the mTOR-DEPTOR Pathway by CRL E3 Ubiquitin Ligases: Therapeutic Application
Zhao, Y., & Sun, Y. (2012) · Neoplasia · doi:10.1593/neo.12532 · Cited by 68
Jia, H., Liu, W., Zhang, B., Wang, J., Wu, P., Tandra, N., Liang, Z., Ji, C., Yin, L., Hu, X., et al. (2018) · PubMed Central · Cited by 67
Oxygen-sensitive methylation of ULK1 is required for hypoxia-induced autophagy
Li, J., Zhang, T., Ren, T., Liao, X., Hao, Y., Lim, J. S., Lee, J.-H., Li, M., Shao, J., & Liu, R. R. (2022) · Nature Communications · doi:10.1038/s41467-022-28831-6 · Cited by 68
Thompson, J. W., Nagel, J., Hoving, S., Gerrits, B., Bauer, A., Thomas, J. R., Kirschner, M. W., Schirle, M., & Luchansky, S. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573352 · Cited by 69
Qin, W., Pan, J., Wu, Y., Bauman, W. A., & Cardozo, C. P. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.061 · Cited by 68
REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch
Miyazaki, M., & Esser, K. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00464.2008 · Cited by 69
Senolytic treatment rescues blunted muscle hypertrophy in old mice
Dungan, C. M., Figueiredo, V. C., Wen, Y., VonLehmden, G. L., Zdunek, C. J., Thomas, N. T., Mobley, C. B., Murach, K. A., Brightwell, C. R., Long, D. E., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00542-2 · Cited by 65
Semba, R. D., Trehan, I., González‐Freire, M., Kraemer, K., Moaddel, R., Ordiz, M. I., Ferrucci, L., & MANARY, M. J. (2016) · Advances in Nutrition · doi:10.3945/an.116.013276 · Cited by 74
Hypoxia induces a phase transition within a kinase signaling network in cancer cells
Wei, W., Shi, Q., Remacle, F., Qin, L., Shackelford, D. B., Shin, Y. S., Mischel, P. S., Levine, R. D., & Heath, J. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303060110 · Cited by 63
mTOR Signaling in Kidney Diseases
Gui, Y., & Dai, C. (2020) · Kidney360 · doi:10.34067/kid.0003782020 · Cited by 66
Exploiting mTOR Signaling: A Novel Translatable Treatment Strategy for Traumatic Optic Neuropathy?
Morgan-Warren, P. J., Berry, M., Ahmed, Z., Scott, R. A. H., & Logan, A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12803 · Cited by 63
Evolutionarily conserved regulation of TOR signalling
Takahara, T., & Maeda, T. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt047 · Cited by 64
Baida, G. E., Bhalla, P., Игоревич, К. К., Lesovaya, E. A., Геннадиевна, Я. М., Yuen, K., Guo, S., Lavker, R. M., Readhead, B., Dudley, J. T., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404601 · Cited by 66
Ikhlas, S., & Ahmad, M. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.029 · Cited by 66
Waickman, A. T., & Powell, J. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103143 · Cited by 64
de Cavanagh, E. M. V., Inserra, F., & Ferder, L. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2014 · Cited by 66
The mTOR pathway in reproduction: from gonadal function to developmental coordination
Correia, B., Sousa, M. I., & Ramalho‐Santos, J. (2019) · Reproduction · doi:10.1530/rep-19-0057 · Cited by 65
REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injury
Morquette, B., Morquette, P., Agostinone, J., Feinstein, E., McKinney, R. A., Kolta, A., & Di Polo, A. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.149 · Cited by 60
Cutting through the Complexities of mTOR for the Treatment of Stroke
Maiese, K. (2014) · Current Neurovascular Research · doi:10.2174/1567202611666140408104831 · Cited by 61
Melnik, B. C., John, S. M., Carrera‐Bastos, P., & Cordain, L. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-74 · Cited by 63
Tidal and diel orchestration of behaviour and gene expression in an intertidal mollusc
Schnytzer, Y., Simon-Blecher, N., Li, J., Waldman Ben-Asher, H., Salmon-Divon, M., Achituv, Y., Hughes, M. E., & Levy, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-23167-y · Cited by 58
Implication of REDD1 in the activation of inflammatory pathways
Pastor, F., Dumas, K., Barthelemy, M., Regazzetti, C., Druelle, N., Peraldi, P., Cormont, M., Tanti, J., & Giorgetti-Peraldi, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-07182-z · Cited by 55
Regulation of vitamin metabolism by p53 and p63 in development and cancer
Zhou, H., & van Bokhoven, H. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12591 · Cited by 61
RTP801/REDD1 Regulates the Timing of Cortical Neurogenesis and Neuron Migration
Malagelada, C., López-Toledano, M. A., Willett, R. T., Jin, Z. H., Shelanski, M. L., & Greene, L. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4011-10.2011 · Cited by 60
Aging accentuates alcohol-induced decrease in protein synthesis in gastrocnemius
Korzick, D. H., Sharda, D. R., Pruznak, A. M., & Lang, C. H. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00083.2013 · Cited by 60
Stevens, A. M., Xiang, M. H., Heppler, L. N., Tošić, I., Jiang, K., Munoz, J. O., Gaikwad, A. S., Horton, T. M., Long, X., Narayanan, P., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000499 · Cited by 59
Ho, K., Chen, P., Chou, C., Shih, C.-M., Lee, Y., Cheng, C., & Chen, K. (2020) · Neurotherapeutics · doi:10.1007/s13311-019-00826-0 · Cited by 59
The stress-responsive protein REDD1 and its pathophysiological functions
Kim, J., Kwon, Y., & Kim, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01056-3 · Cited by 71
Insulin Induces REDD1 Expression through Hypoxia-inducible Factor 1 Activation in Adipocytes
Regazzetti, C., Bost, F., MARCHAND‐BRUSTEL, Y. L., Tanti, J., & Giorgetti‐Peraldi, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047688 · Cited by 67
Cam, M., Bid, H. K., Xiao, L., Zambetti, G. P., Houghton, P. J., & Çam, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.530303 · Cited by 60
Chemoprevention Meets Glucose Control
Engelman, J. A., & Cantley, L. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0178 · Cited by 58
CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress
Lerchenmüller, C., Rabolli, C. P., Yeri, A., Kitchen, R. R., Salvador, A. M., Liu, L. X., Ziegler, O., Danielson, K., Platt, C., Shah, R. V., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315881 · Cited by 58
mTOR signaling: RAG GTPases transmit the amino acid signal
Shaw, R. J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.09.005 · Cited by 58
Lymphangioleiomyomatosis (LAM): Molecular insights lead to targeted therapies
Glasgow, C. G., Steagall, W. K., Taveira‐DaSilva, A. M., Pacheco–Rodriguez, G., Cai, X., El‐Chemaly, S., Moses, M. A., Darling, T. N., & Moss, J. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.03.017 · Cited by 57
Pharmacological regulators of autophagy and their link with modulators of lupus disease
Gros, F., & Muller, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12792 · Cited by 60
Álvarez-García, Ó., Olmer, M., Akagi, R., Akasaki, Y., Fisch, K. M., Shen, T., Su, A. I., & Lotz, M. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.04.015 · Cited by 60
Molecular Mechanisms Controlled by mTOR in Male Reproductive System
Moreira, B. P., Oliveira, P. F., & Alves, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071633 · Cited by 59
mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus
Maiese, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.217 · Cited by 58
Canal, M., Romaní-Aumedes, J., Martín‐Flores, N., Pérez-Fernández, V., & Malagelada, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00313 · Cited by 65
Kfir‐Erenfeld, S., Sionov, R. V., Spokoini, R., Cohen, O., & Yefenof, E. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.506570 · Cited by 57
DDIT4/REDD1/RTP801 Is a Novel Negative Regulator of Schwann Cell Myelination
Noseda, R., Belin, S., Piguet, F., Vaccari, I., Scarlino, S., Brambilla, P., Boneschi, F. M., Feltri, M. L., Wrabetz, L. G., Quattrini, A., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2408-13.2013 · Cited by 58
Effect of acute environmental hypoxia on protein metabolism in human skeletal muscle
D’Hulst, G., Jamart, C., Thienen, R. V., Hespel, P., Francaux, M., & Deldicque, L. (2013) · Acta Physiologica · doi:10.1111/apha.12086 · Cited by 57
Watson, A., Lipina, C., McArdle, H. J., Taylor, P. M., & Hundal, H. S. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.01.014 · Cited by 55
Is REDD1 a Metabolic Éminence Grise ?
Lipina, C., & Hundal, H. S. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.08.005 · Cited by 60
Investigating Glioblastoma Response to Hypoxia
Chédeville, A. L., Lourdusamy, A., Monteiro, A. R., Hill, R., & Madureira, P. A. (2020) · Biomedicines · doi:10.3390/biomedicines8090310 · Cited by 55
Therapeutic targeting of autophagy in cancer. Part I: Molecular pathways controlling autophagy
Nagelkerke, A., Sweep, F. C. G. J., Geurts-Moespot, A. J., Bussink, J., & Span, P. N. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.05.004 · Cited by 55
A review of the mechanism of DDIT4 serve as a mitochondrial related protein in tumor regulation
Ding, F., Gao, F., Zhang, S., Lv, X., Chen, Y., & Liu, Q. (2021) · Science Progress · doi:10.1177/0036850421997273 · Cited by 56
Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma
Wu, Y., Jan, Y., Ko, B., Liang, S.-M., & Liou, J. (2015) · Cancers · doi:10.3390/cancers7020822 · Cited by 54
Martelli, A. M., Evangelisti, C., Chiarini, F., Grimaldi, C., & McCubrey, J. A. (2010) · Cancers · doi:10.3390/cancers2031576 · Cited by 57
Oh, S., & Roh, C. (2017) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2017.60.3.241 · Cited by 53
Britto, F. A., Cortade, F., Belloum, Y., Blaquière, M., Gallot, Y. S., Docquier, A., Pagano, A. F., Jublanc, É., Bendridi, N., Koechlin‐Ramonatxo, C., et al. (2018) · BMC Biology · doi:10.1186/s12915-018-0525-4 · Cited by 68
The mTOR pathway negatively controls ATM by up-regulating miRNAs
Shen, C., & Houghton, P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220898110 · Cited by 50
Dufour, M., Dormond-Meuwly, A., Demartines, N., & Dormond, O. (2011) · Cancers · doi:10.3390/cancers3022478 · Cited by 55
Hitting the Golden TORget: Curcumin’s Effects on mTOR Signaling
Beevers, C. S., Zhou, H., & Huang, S. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313070004 · Cited by 53
Regulation of alveolar macrophage death in pulmonary fibrosis: a review
Yang, G., Yang, Y., Liu, Y., & Liu, X. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01888-4 · Cited by 57
Kazi, A. A., Pruznak, A. M., Frost, R. A., & Lang, C. H. (2010) · Shock · doi:10.1097/shk.0b013e3181ecb57c · Cited by 52
Mitochondria mediated cell death in diabetes
Szabadkai, G., & Duchen, M. R. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0363-5 · Cited by 54
REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumorsPreprint
Qiao, S., Koh, S., Vivekanandan, V., Salunke, D., Patra, K. C., Zaganjor, E., Ross, K. N., Mizukami, Y., Jeanfavre, S., Chen, A. L., et al. (2020) · Genes & Development · doi:10.1101/gad.335166.119 · Cited by 52
Self-citationKosakamoto, H., Okamoto, N., Aikawa, H., Sugiura, Y., Suematsu, M., Niwa, R., Miura, M., & Obata, F. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00608-7 · Cited by 46
Malik, A. R., Urbańska, M., Macias, M., Skalecka, A., & Jaworski, J. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.12.010 · Cited by 56
The cross talk of two family members of β-TrCP in the regulation of cell autophagy and growth
Cui, D., Dai, X.-Q., Shu, J., Ma, Y., Wei, D., Xiong, X., & Zhao, Y. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0402-x · Cited by 50
Yang, C.-S., Matsuura, K., Huang, N.-J., Robeson, A. C., Huang, B., Zhang, L., & Kornbluth, S. A. (2014) · Oncogene · doi:10.1038/onc.2014.271 · Cited by 50
Malaguarnera, R., Sacco, A., Morcavallo, A., Squatrito, S., Migliaccio, A., Morrione, A., Maggiolini, M., & Belfiore, A. (2014) · Endocrinology · doi:10.1210/en.2013-1925 · Cited by 50
Williamson, D. L., Li, Z., Tuder, R. M., Feinstein, E., Kimball, S. R., & Dungan, C. M. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01350.2013 · Cited by 54
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?
Lamberti, G., Brighi, N., Maggio, I., Manuzzi, L., Peterle, C., Ambrosini, V., Ricci, C., Casadei, R., & Campana, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030747 · Cited by 51
Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
Groenewoud, M. J., & Zwartkruis, F. J. T. (2013) · Open Biology · doi:10.1098/rsob.130185 · Cited by 51
Mammalian target of rapamycin (mTOR): a central regulator of male fertility?
Jesus, T. T., Oliveira, P. F., Sousa, M., Cheng, C. Y., & Alves, M. G. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1279120 · Cited by 50
Ambient hypoxia enhances the loss of muscle mass after extensive injury
Chaillou, T., Koulmann, N., Meunier, A., Pugnière, P., McCarthy, J. J., Beaudry, M., & Bigard, X. A. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1336-7 · Cited by 48
Hundahl, C. A., Luuk, H., Ilmjärv, S., Falktoft, B., Raida, Z., Vikesaa, J., Friis-Hansen, L. J., & Hay‐Schmidt, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028160 · Cited by 48
Alqurashi, N., Hashimi, S. M., & Wei, M. Q. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023874 · Cited by 47
Anatomy of autophagy: from the beginning to the end
Zhi, X., Feng, W., Rong, Y., & Liu, R. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2657-z · Cited by 48
Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment
Schito, L. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00209.2018 · Cited by 49
PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease
Morel, M., Couturier, J., Lafay‐Chebassier, C., Paccalin, M., & Page, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00849.x · Cited by 47
A new mathematical approach for qualitative modeling of the insulin-TOR-MAPK network
Nijhout, H. F., & Callier, V. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00245 · Cited by 47
Regazzetti, C., Dumas, K., MARCHAND‐BRUSTEL, Y. L., Peraldi, P., Tanti, J., & Giorgetti‐Peraldi, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052154 · Cited by 47
Wen, Y., Stevens, P. D., Gasser, M. L., Andrei, R., & Gao, T. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00695-13 · Cited by 49
Feedback Control of p53 Translation by REDD1 and mTORC1 Limits the p53-Dependent DNA Damage Response
Vadysirisack, D. D., Baenke, F., Ory, B., Lei, K., & Ellisen, L. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05541-11 · Cited by 51
Self-citationGordon, B. S., Steiner, J. L., Williamson, D. L., Lang, C. H., & Kimball, S. R. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00059.2016 · Cited by 49
A Microdevice Platform Recapitulating Hypoxic Tumor Microenvironments
Ando, Y., Ta, H. P., Yen, D. P., Lee, S., Raola, S., & Shen, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-15583-3 · Cited by 49
Vadysirisack, D. D., & Ellisen, L. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_4 · Cited by 49
Self-citationChen, Z., Holland, W. L., Shelton, J. M., Ali, A., Zhan, X., Won, S., Tomisato, W., Liu, C., Li, X., Moresco, E. M. Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406511111 · Cited by 46
Jessica, P., Bongartz, H., Klepsch, O., Wundrack, N., Poli, V., Schaper, F., & Dittrich, A. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.04.004 · Cited by 50
Metadata
- Authors
- DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W.
- Affiliations
- Harvard University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2008-01-15
- Volume
- 22
- Issue
- 2
- Pages
- 239-251
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC2192757
- OpenAlex
- W2130396048
- Cited by
- 710
- References
- 41
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 17 · 2023: 32 · 2022: 37 · 2021: 43 · 2020: 34 · 2019: 38 · 2018: 41 · 2017: 42 · 2016: 44 · 2015: 42 · 2014: 48 · 2013: 45 · 2012: 47
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA122589)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- hypoxia, TSC1/2, mTORC1, REDD1, 14-3-3 proteins, TORC1 inhibition, tumor suppression, anchorage-independent growth, carcinogenesis, cellular metabolism, signal integration
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Animals, Breast Neoplasms, Cells, Cultured, Humans, Mice, Nude, Models, Biological, Neoplasm Transplantation, Protein Kinases, Transcription Factors, Signal Transduction, Cell Hypoxia, Tumor Suppressor Proteins, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review